Actively Recruiting
Long-term Study on Central Nervous System Vasculitis to Understand Disease and Treatments
Led by University of Pennsylvania · Updated on 2026-01-23
40
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating primary central nervous system vasculitis CNSV, a rare and potentially fatal disease affecting the brains blood vessels. CNSV can cause serious neurological problems such as strokes, speech and cognitive impairments, vision loss, dementia, and encephalopathy. This study aims to create a research group to better understand the disease process, treatments, and patient outcomes using a multicenter approach to overcome previous study limitations. Participants will be followed over three years with study visits every three months during the first year and annually for the next two years. At each visit, blood samples will be collected, and physical exams, medical history reviews, and medication histories will be conducted. Participants will also complete questionnaires assessing disease activity, health status, and lifestyle factors such as tobacco, alcohol, and drug use. Throughout the study, researchers will evaluate the diseases development and progression by reviewing patient history and biomolecular data collected over 36 months. The study will also use PROMIS questionnaires at multiple time points to assess patient-reported outcomes. This long-term monitoring will help deepen understanding of CNSVs natural history, genetic basis, and identify biomarkers for disease activity and prognosis.
CONDITIONS
Brief Title
Longitudinal Study for Central Nervous System Vasculitis
Research Team
C
Carol McAlear
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here